Mother and son walking outside
Supporting your MPS II journey

ELAPRASE STORAGE
& HANDLING

ELAPRASE should be administered by a qualified healthcare professional, with appropriate emergency medical support readily available.

ELAPRASE box and vial

Where permitted by local healthcare and reimbursement policy, home infusion of ELAPRASE may be possible. When a doctor has determined that home infusion is appropriate, the doctor should ensure that patients and caregivers understand all relevant storage and handling instructions that may apply in a home infusion setting.

ELAPRASE requires special storage conditions. Important ELAPRASE storage and handling instructions include:*

Storing ELAPRASE

ELAPRASE is stored in single-use vials, and the carton containing the ELAPRASE vials should be stored in a refrigerator at 36 °F to 46 °F (2 °C to 8 °C) to protect it from light. Do not freeze ELAPRASE.

ELAPRASE vials are single use. Any unused product or waste material should be discarded and disposed of in accordance with local requirements.

Keep ELAPRASE and all medicines out of the reach of children.

Handling ELAPRASE

Do not shake ELAPRASE.

Do not use ELAPRASE after the expiration date on the vial.

ELAPRASE box and vial

ELAPRASE does not contain preservatives; therefore, after dilution with saline, the diluted solution should be used immediately. If immediate use is not possible, the diluted solution should be stored refrigerated at 36 °F to 46 °F (2 °C to 8 °C) for up to 24 hours. Other than during infusion, do not store the diluted ELAPRASE solution at room temperature.

*Home infusion patients and caregivers should discuss

complete storage and handling conditions with their doctor.

Important Safety Information
Important Safety Information

RISK OF SERIOUS ALLERGIC REACTIONS

Some patients have experienced serious allergic reactions (including life-threatening anaphylactic reactions) during and up to 24 hours after treatment, regardless of how long they were taking ELAPRASE. Anaphylactic reactions are immediate and include breathing problems, low oxygen levels, low blood pressure, hives and/or swelling of the throat or tongue. If a patient (you or your child) has experienced an anaphylactic reaction, the patient may require an extended period of observation by the patient’s healthcare team. If you or your child has breathing problems, a fever, or a respiratory illness, you or your child may be at risk of life-threatening worsening of those conditions due to allergic reactions from ELAPRASE. Your healthcare team should be advised of those conditions before treatment with ELAPRASE because the information may affect the timing of ELAPRASE treatment.